[1]
Webster, MD, L., Tummala, MD, MBA, MS, R., Diva, PhD, U. and Lappalainen, MD, PhD, J. 2016. A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipation. Journal of Opioid Management. 12, 6 (Nov. 2016), 405–419. DOI:https://doi.org/10.5055/jom.2016.0360.